![]() |
市場調査レポート
商品コード
1593487
乳房画像診断の市場規模・シェア・成長分析 (技術別、製品別、最終用途別、地域別):産業予測 (2024~2031年)Breast Imaging Market Size, Share, Growth Analysis, By Technology (Ionizing, Non-Ionizing), By Product (Breast Imaging Systems, Software & Services), By End Use (Breast Care Centers, Diagnostic Imaging Centers), By Region - Industry Forecast 2024-2031 |
||||||
|
乳房画像診断の市場規模・シェア・成長分析 (技術別、製品別、最終用途別、地域別):産業予測 (2024~2031年) |
出版日: 2024年11月10日
発行: SkyQuest
ページ情報: 英文 194 Pages
納期: 3~5営業日
|
世界の乳房画像診断の市場規模は、2022年には約40億3,000万米ドルと評価され、2023年の44億米ドルから、2031年には84億5,000万米ドルに成長し、予測期間 (2024~2031年) のCAGRは8.5%に達する、と予測されています。
乳房画像診断の世界市場は、乳がん罹患率の増加と画像技術の進歩に牽引され、大きく成長する見通しです。乳がんに対する意識の高まりや早期発見の促進を目指した取り組みが、乳房画像診断ソリューションの需要をさらに刺激すると予想されます。個別化医療への動向は、高度な画像処理へのアクセスの増加と相まって、乳房画像診断プロバイダーに新たな機会をもたらしています。さらに、乳がん調査への投資の増加や革新的な画像処理技術の開発は、この分野のさらなる成長の道を切り開くものと思われます。しかし、放射線被ばくへの懸念、高度な画像技術に関連する高コスト、検診ガイドラインの標準化の欠如などの課題に直面する可能性があり、それが市場参入者にとって大きな障害となることが予想されます。今後数年間、乳房画像診断サービスや技術に対する急増する需要を生かそうとする企業にとって、この阻害要因に対処することは極めて重要となるでしょう。
Global Breast Imaging Market size was valued at around USD 4.03 billion in 2022 and is expected to rise from USD 4.40 billion in 2023 to reach a value of USD 8.45 billion by 2031, at a CAGR of 8.5% over the forecast period (2024-2031).
The global market for breast imaging is poised for significant growth, driven by the increasing incidence of breast cancer and advancements in imaging technologies. Heightened awareness of breast cancer and initiatives aimed at promoting early detection are expected to further stimulate demand for breast imaging solutions. The trend towards personalized medicine, coupled with the growing accessibility of advanced imaging procedures, presents new opportunities for breast imaging providers. Additionally, increased investments in breast cancer research and the development of innovative imaging technologies are likely to create further avenues for growth in this sector. However, the market may face challenges, including concerns about radiation exposure, the high costs associated with advanced imaging technologies, and the absence of standardized screening guidelines, which are anticipated to be significant obstacles for market players. Addressing these restraints will be crucial for companies looking to capitalize on the burgeoning demand for breast imaging services and technologies in the years to come.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Breast Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Breast Imaging Market Segmental Analysis
Global Breast Imaging Market is segmented by Technology, Product, End User, and Region. Based on Technology, the market is segmented into Ionizing (Full-field Digital Mammography, Analog Mammography, Positron Emission Mammography, Electric Impedance Tomography, Cone-Beam Computed Tomography, Positron Emission Tomography & Computed Tomography, 3D Breast Tomosynthesis, and MBI/BSGI), Non-Ionizing (MRI, Thermography, Ultrasound, Optical Imaging, Automated Whole-breast Ultrasound). Based on Product, the market is segmented into Breast Imaging Systems, Software & Services, and Accessories. Based on End User, the market is segmented into Hospitals & Surgical Centers, Ambulatory Care Centers, Research Laboratories & Academic Institutes, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Driver of the Global Breast Imaging Market
The Global Breast Imaging market is significantly driven by increasing investments in medical imaging research and development, leading to the emergence of innovative breast imaging technologies and devices. These advanced solutions enhance the accuracy and efficacy of breast cancer diagnosis and treatment, making them indispensable in clinical settings. As healthcare providers increasingly adopt these superior imaging modalities to improve patient outcomes, the growing prevalence of breast cancer globally further amplifies market demand. This trend not only reflects the commitment to elevated healthcare standards but also underscores the necessity for continued advancements in breast imaging, fostering a robust and expanding market landscape in the coming years.
Restraints in the Global Breast Imaging Market
One significant market restraint for the Global Breast Imaging market is the concern surrounding radiation exposure associated with certain imaging technologies, such as mammography. This apprehension is particularly pertinent for women who are at a lower risk of developing breast cancer, as they may perceive the risks of radiation exposure as outweighing the benefits of early detection. Such fears could lead to reduced acceptance and demand for breast imaging services, potentially slowing market growth. Additionally, this concern could drive a preference for alternative imaging modalities perceived as safer, further impacting the adoption rates of conventional breast imaging technologies in the future.
Market Trends of the Global Breast Imaging Market
The Global Breast Imaging market is witnessing a significant trend towards the integration of Artificial Intelligence (AI) and Machine Learning (ML) technologies. These advancements are being increasingly adopted by breast imaging providers to automate processes, enhance diagnostic accuracy, and improve operational efficiency. AI and ML frameworks facilitate the analysis of imaging data, allowing for better detection and characterization of breast lesions. This technological evolution not only streamlines workflow but also elevates the performance of imaging modalities, thus driving growth in patient outcomes and market demand. Consequently, this trend is poised to reshape the landscape of breast imaging, making it more precise and efficient.